Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Diabetes|August 28, 2004
Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejectionDongmei Han, Xiumin Xu, David Baidal, et al.
Nutrients|December 11, 2019
The Role of Vitamin D and Omega-3 PUFAs in Islet TransplantationMarco Infante, Camillo Ricordi, Nathalia Padilla, et al.
Nutrients|September 14, 2019
Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 DiabetesMarco Infante, Camillo Ricordi, Janine Sanchez, et al.
Diabetes, Obesity & Metabolism|June 24, 2020
Exenatide extended release in patients with type 1 diabetes with and without residual insulin productionKevan C Herold, Jesse Reynolds, James Dziura, et al.
Frontiers in Immunology|April 7, 2023
Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantationCassandra Ballou, Franca Barton, Elizabeth H Payne, et al.
Transplantation|January 22, 2021
Long-term Persistence of Allosensitization After Islet Allograft FailurePaola Rios, David Baidal, Joana Lemos, et al.
Frontiers in Endocrinology|January 24, 2022
Islets Transplantation at a Crossroads - Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association CongressPiotr Witkowski, Louis H Philipson, John B Buse, et al.
Diabetes Care|July 18, 2018
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 DiabetesMichael J Haller, Desmond A Schatz, Jay S Skyler, et al.
Stem Cells Translational Medicine|January 5, 2021
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trialGiacomo Lanzoni, Elina Linetsky, Diego Correa, et al.
Pageof 1